Lidocaine and Magnesium and Ketamine in Gynecological Surgery
Unknown statusNot applicableNCT04622904
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study will be to investigate the effect of a combination of intravenous infusions of lidocaine and magnesium versus a combination of intravenous infusions of lidocaine and ketamine versus an intravenous infusion of lidocaine alone on recovery profile, quality of recovery and postoperative pain after elective gynecological surgery
Study details
- Official title
- The Effect of Intravenous Infusions of Lidocaine and Magnesium Versus Lidocaine and Ketamine Versus Lidocaine Alone on Recovery Profile and Postoperative Pain After Elective Gynecological Surgery
- Conditions
- Pain, Postoperative
- Pain, Acute
- Pain, Chronic
- Pain, Neuropathic
- Lidocaine
- Ketamine
- Magnesium
- Central Nervous System Depressants
- Analgesics
- Neurotransmitter Agents
- Analgesics, Non-narcotic
- Interventions
- Drug: lidocaine-magnesium infusion
- Drug: lidocaine-ketamine infusion
- Drug: lidocaine infusion
- Sponsor
- Aretaieion University Hospital
- Start date
- 2020-11-14
- Primary completion
- 2023-11
- Sex
- Female
- Age range
- from 25 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Greece
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * adult female patients * American Society of Anesthesiologists (ASA) classification I-II * elective open gynecological surgery Exclusion Criteria: * body mass index (BMI) \>35 kg/m2 * contraindications to local anesthetic administration or non-steroidal agents administration * systematic use of analgesic agents preoperatively * chronic pain syndromes preoperatively * neurological or psychiatric disease on treatment * pregnancy * severe hepatic or renal disease * history of cardiovascular diseases/ arrhythmias/ conduction abnormalities * drug or alcohol abuse * language or communication barriers * lack of informed consent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04622904